The Lancet Haematology

SJR Rank #166H-index: 113SJR: 6.899Best quartile: Q1APC: US$7,280
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • HematologyQ1

Areas: Medicine

Most published research topics

Lymphoma Diagnosis and TreatmentMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchHemoglobinopathies and Related DisordersChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationVenous Thromboembolism Diagnosis and Management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

2352-3026, 2451-9960

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.50

References per Document

19.22

Coverage

2014-2026

Scope

The Lancet Haematology launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice. Building on the Lancet journals' reputation for publishing high-impact research, The Lancet Haematology is expected to attain the same standing and reputation in its discipline as its sister Lancet journals, and will maintain similar high reporting standards as all Lancet titles.

Metrics from SCImago Journal Rank 2025. View on SCImago